The missense mutation of TP53 is very common in human cancers, which can lead to the inactivation of the tumor suppressive effect of mutant p53 protein, which is conducive to the proliferation and survival of cancer cells, thus promoting tumor invasion, migration and chemotherapy resistance [42, 43]. This evidence concerns the gene TP53 and cancer.